Atropine Sulfate Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Jan 1, 2012.

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-9630-05
Dosage Form
Injection
Presentation
Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05)
Initial Posting
Jan 1, 2012

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.